| User's Publication |
|
13416
Sagara M, Miyamoto S, Itoh S, Soda Y, Tani K.
Development of New Oncolytic Virotherapy Targeting Breast Cancer Using Coxsackievirus B3.
Anticancer Res
2021
PubMed ID: 33419801
|
|
20159
Sakabe T, Wakahara M, Shiota G, Umekita Y.
Role of cytoplasmic localization of maspin in promoting cell invasion in breast cancer with aggressive phenotype.
Sci Rep
2021
11(1):11321
PubMed ID: 34059749
|
|
16735
Okada H, Mimura M, Tomita S, Kurita R.
Affinity Diversification of a Polymer Probe for Pattern-recognition-based Biosensing Using Chemical Additives
Anal Sci
2021
37(5):713-719
PubMed ID: 33518589
|
|
11952
Kimura R, Yoshimaru T, Matsushita Y, Matsuo T, Ono M, Park JH, Sasa M, Miyoshi Y, Nakamura Y, Katagiri T.
The GALNT6‑LGALS3BP axis promotes breast cancer cell growth.
Int. J. Oncol.
2020
PubMed ID: 31894262
|
|
12064
Teraoka S, Muguruma M, Takano N, Miyahara K, Kawate T, Kaise H, Yamada K, Miyazawa K, Ishikawa T.
Association of BRCA Mutantations and BRCAness Status With Anticancer Drug Sensitivities in Triple-Negative Breast Cancer Cell Lines.
J. Surg. Res.
2020
PubMed ID: 32092597
|
|
13226
Muguruma M, Teraoka S, Miyahara K, Ueda A, Asaoka M, Okazaki M, Kawate T, Kuroda M, Miyagi Y, Ishikawa T.
Differences in drug sensitivity between two-dimensional and three-dimensional culture systems in triple-negative breast cancer cell lines.
Biochem Biophys Res Commun
2020
PubMed ID: 32958246
|
|
13770
Kim H, Hoshi M, Iijima M, Kuroda S, Nakamura C.
Development of a universal method for the measurement of binding affinities of antibody drugs towards a living cell based on AFM force spectroscopy
Anal Methods
2020
12(22):2922-2927
PubMed ID: 32930215
|
|
14854
Terasaki A, Kurokawa H, Ito H, Komatsu Y, Matano D, Terasaki M, Bando H, Hara H, Matsui H.
Elevated Production of Mitochondrial Reactive Oxygen Species via Hyperthermia Enhanced Cytotoxic Effect of Doxorubicin in Human Breast Cancer Cell Lines MDA-MB-453 and MCF-7
Int J Mol Sci
2020
21(24):9522
PubMed ID: 33333736
|
|
11511
Behan FM, Iorio F, Picco G, Gonçalves E, Beaver CM, Migliardi G, Santos R, Rao Y, Sassi F, Pinnelli M, Ansari R, Harper S, Jackson DA, McRae R, Pooley R, Wilkinson P, van der Meer D, Dow D, Buser-Doepner C, Bertotti A, Trusolino L, Stronach EA, Saez-Rodriguez J, Yusa K, Garnett MJ.
Prioritization of cancer therapeutic targets using CRISPR-Cas9 screens.
Nature
2019
PubMed ID: 30971826
|
|
11524
Ueda A, Oikawa K, Fujita K, Ishikawa A, Sato E, Ishikawa T, Kuroda M, Kanekura K.
Therapeutic potential of PLK1 inhibition in triple-negative breast cancer.
Lab. Invest.
2019
PubMed ID: 30996295
|
|
11563
Kawase A, Inoue Y, Nakazaki S, Koizumi E, Iwaki M.
Radixin knockdown improves the accumulation and efficiency of methotrexate in tumor cells.
Oncol. Rep.
2019
PubMed ID: 31115547
|
|
14819
Takayama M, Takatsu H, Hamamoto A, Inoue H, Naito T, Nakayama K, Shin HW.
The cytoplasmic C-terminal region of the ATP11C variant determines its localization at the polarized plasma membrane
J Cell Sci
2019
132(17):jcs231720.
PubMed ID: 31371488
|
|
11228
Ichihara H, Okumura M, Tsujimura K, Matsumoto Y.
Theranostics with Hybrid Liposomes in an Orthotopic Graft Model Mice of Breast Cancer.
Anticancer Res.
2018
PubMed ID: 30275183
|
|
4120
Miyagawa Y, Matsushita Y, Suzuki H, Komatsu M, Yoshimaru T, Kimura R, Yanai A, Honda J, Tangoku A, Sasa M, Miyoshi Y, Katagiri T.
Frequent downregulation of LRRC26 by epigenetic alterations is involved in the malignant progression of triple-negative breast cancer.
Int. J. Oncol.
2018
PubMed ID: 29512727
|
|
4288
Khatun A, Shimozawa M, Kito H, Kawaguchi M, Fujimoto M, Ri M, Kajikuri J, Niwa S, Fujii M, Ohya S.
Transcriptional Repression and Protein Degradation of the Ca2+-Activated K+ Channel KCa1.1 by Androgen Receptor Inhibition in Human Breast Cancer Cells.
Front Physiol
2018
PubMed ID: 29713287
|
|
4376
Fujimoto M, Kito H, Kajikuri J, Ohya S.
Transcriptional repression of human epidermal growth factor receptor 2 by ClC-3 Cl- /H+ transporter inhibition in human breast cancer cells.
Cancer Sci.
2018
109(9):2781-2791
PubMed ID: 29949674
|
|
9925
Fujimoto M, Inoue T, Kito H, Niwa S, Suzuki T, Muraki K, Ohya S.
Transcriptional repression of HER2 by ANO1 Cl- channel inhibition in human breast cancer cells with resistance to trastuzumab.
Biochem. Biophys. Res. Commun.
2017
482:188-194
PubMed ID: 27838298
|
|
10445
Yamaguchi H, Ito Y, Miura N, Nagamura Y, Nakabo A, Fukami K, Honda K, Sakai R.
Actinin-1 and actinin-4 play essential but distinct roles in invadopodia formation by carcinoma cells.
Eur. J. Cell Biol.
2017
96:685-694
PubMed ID: 28797528
|
|
5680
Ginting TE, Suryatenggara J, Christian S, Mathew G.
Proinflammatory response induced by Newcastle disease virus in tumor and normal cells.
Oncolytic Virother
2017
6:21-30
PubMed ID: 28293547
|
|
14384
Miyasato Y, Shiota T, Ohnishi K, Pan C, Yano H, Horlad H, Yamamoto Y, Yamamoto-Ibusuki M, Iwase H, Takeya M, Komohara Y.
High density of CD204-positive macrophages predicts worse clinical prognosis in patients with breast cancer
Cancer Sci
2017
108(8):1693-1700
PubMed ID: 28574667
|
|
9818
Kanzaki H, Shinohara F, Suzuki M, Wada S, Miyamoto Y, Yamaguchi Y, Katsumata Y, Makihira S, Kawai T, Taubman MA, Nakamura Y.
A-Disintegrin and Metalloproteinase (ADAM) 17 Enzymatically Degrades Interferon-gamma.
Sci Rep
2016
6:32259
PubMed ID: 27573075
|
|
9880
Poulose AC, Veeranarayanan S, Mohamed MS, Aburto RR, Mitcham T, Bouchard RR, Ajayan PM, Sakamoto Y, Maekawa T, Kumar DS.
Multifunctional Cu2-xTe Nanocubes Mediated Combination Therapy for Multi-Drug Resistant MDA MB 453.
Sci Rep
2016
6:35961
PubMed ID: 27775048
|
|
9992
Khatun A, Fujimoto M, Kito H, Niwa S, Suzuki T, Ohya S.
Down-Regulation of Ca2+-Activated K⁺ Channel KCa1.1 in Human Breast Cancer MDA-MB-453 Cells Treated with Vitamin D Receptor Agonists.
Int J Mol Sci
2016
17:
PubMed ID: 27973439
|
|
12882
Kikuchi M, Yamashita K, Waraya M, Minatani N, Ushiku H, Kojo K, Ema A, Kosaka Y, Katoh H, Sengoku N, Enomoto T, Tanino H, Sawanobori M, Watanabe M.
Epigenetic regulation of ZEB1-RAB25/ESRP1 axis plays a critical role in phenylbutyrate treatment-resistant breast cancer
Oncotarget
2016
7(2):1741-53.
PubMed ID: 26646320
|
|
7226
Subramanian N, Kanwar JR, Kanwar RK, Krishnakumar S.
Targeting Cancer Cells Using LNA-Modified Aptamer-siRNA Chimeras.
Nucleic Acid Ther
2015
25:317-22
PubMed ID: 26334953
|
|
7287
Iida R, Ueki M, Yasuda T.
Identification of interacting partners of Human Mpv17-like protein with a mitigating effect of mitochondrial dysfunction through mtDNA damage.
Free Radic. Biol. Med.
2015
87:336-45
PubMed ID: 26165189
|
|
9408
Yasunori Sato, Naoto Sasaki, Megu Saito, Nao Endo, Fumihiko Kugawa, Akemichi Ueno
Luteolin Attenuates Doxorubicin-Induced Cytotoxicity to MCF-7 Human Breast Cancer Cells
Biol Pharm Bull
2015
38(5):703-9
PubMed ID: 25947916
|
|
5833
Sato M, Muguruma N, Nakagawa T, Okamoto K, Kimura T, Kitamura S, Yano H, Sannomiya K, Goji T, Miyamoto H, Okahisa T, Mikasa H, Wada S, Iwata M, Takayama T.
High antitumor activity of pladienolide B and its derivative in gastric cancer.
Cancer Sci
2014
105(1):110-6
PubMed ID: 24635824
|
|
15803
M. Sheikh Mohamed, Srivani Veeranarayanan, Hiroaki Minegishi, Yasushi Sakamoto, Yasuhiro Shimane, Yutaka Nagaoka, Atsushi Aki, Aby Cheruvathoor Poulose, Akinobu Echigo, Yasuhiko Yoshida, Toru Maekawa, D. Sakthi Kumar
Cytological and Subcellular Response of Cells Exposed to the Type-1 RIP Curcin and its Hemocompatibility Analysis
Scientific Reports
2014
4
|
|
17110
Masanari Umemura, Ayako Makino, Itaru Sato, Xianfeng Feng, Kayoko Oda, Makoto Ohtake, Satoshi Izuka, Maki Iwai, Kosuke Matsuo, Haruki Eguchi, Yoshihiro Ishikawa
Abstract 5399: A novel treatment for triple-negative breast cancer using intrinsic magnetized paclitaxel
Cancer Research
2014
74:5399-5399
|
|
14401
Yamaguchi Y, Deng D, Sato Y, Hou YT, Watanabe R, Sasaki K, Kawabe M, Hirano E, Morinaga T.
Silicate fiber-based 3D cell culture system for anticancer drug screening
Anticancer Res
2013
33(12):5301-9
PubMed ID: 24324063
|
|
17165
Nakagawa S, Matsuoka Y, Ichihara H, Yoshida H, Yoshida K, Ueoka R.
Therapeutic effects of autologous lymphocytes activated with trastuzumab for xenograft mouse models of human breast cancer
Biol Pharm Bull
2013
36(5):861-5
PubMed ID: 23649343
|
|
7842
Takahashi Y, Iwai M, Kawai T, Arakawa A, Ito T, Sakurai-Yageta M, Ito A, Goto A, Saito M, Kasumi F, Murakami Y.
Aberrant expression of tumor suppressors CADM1 and 4.1B in invasive lesions of primary breast cancer.
Breast Cancer
2011
19:242-52
PubMed ID: 21526423
|
|
5869
Tatsuya Nodagashira，Hiroki Odagiri，Shojiro-Kazunori Ikenaga，Masaki Maruyama， Toshiyuki Sato and Kenichi Hakamada
Efficient gene transduction in HER2-expressing cancer cells by two recombinant adenovirus vectors with HER2 promoter and Cre/loxP system
Hirosaki Med J
2010
61:26―34
|
|
8681
Shinya Shimoda, Hideaki Ichihara, Yoko Matsumoto, Ryuichi Ueoka
Nanoparticles of Hybrid Liposomes for the Inhibition of Breast Tumor Growth along with Apoptosis
Chemistry Letters
2009
38:134-135
|
|
5877
Yamamoto H, Okumura K, Toshima S, Mukaisho K, Sugihara H, Hattori T, Kato M, Asano S.
FXYD3 protein involved in tumor cell proliferation is overproduced in human breast cancer tissues.
Biol Pharm Bull
2009
32(7):1148-54
PubMed ID: 19571376
|
|
12771
Azumi K, Ikeda Y, Takeuchi T, Nomura T, Sabau SV, Hamada J, Okada F, Hosokawa M, Yokosawa H.
Localization and characterization of γ-glutamyl cyclotransferase in cancer cells
Mol Med Rep
2009
2(3):385-91
PubMed ID: 21475839
|
|
5012
Kawakami T, Chano T, Minami K, Okabe H, Okada Y, Okamoto K.
Imprinted DLK1 is a putative tumor suppressor gene and inactivated by epimutation at the region upstream of GTL2 in human renal cell carcinoma.
Hum Mol Genet
2006
15(6):821-30
PubMed ID: 16439445
|
|
2763
Ghosh, Mila, Koike, Naoto, Tsunoda, Shin-Ichi, Hirano, Takashi, Kaul, Sunil, Kashiwagi, Hironobu, Kawamoto, Toru, Ohkohchi, Nobuhiro, Saijo, Kaoru, Ohno, Tadao, Miwa, Masanao, Todoroki, Takeshi
Characterization and genetic analysis in the newly established human bile duct cancer cell lines.
Int J Oncol
2005
26:449-56
PubMed ID: 15645130
|
|
3023
Nishikawa, Kazuhiro, Satoh, Haruna, Hirai, Ayako, Suzuzki, Kazuyuki, Asano, Ryuji, Kumadaki, Itsumaro, Hagiwara, Kiyokazu, Yano, Tomohiro
alpha-Tocopheryloxybutyric acid enhances necrotic cell death in breast cancer cells treated with chemotherapy agent.
Cancer Lett
2003
201:51-6
PubMed ID: 14580686
|
|
3040
Satoh H, Nishikawa K, Suzuki K, Asano R, Virgona N, Ichikawa T, Hagiwara K, Yano T.
Genistein, a soy isoflavone, enhances necrotic-like cell death in a breast cancer cell treated with a chemotherapeutic agent.
Res. Commun. Mol. Pathol. Pharmacol.
2003
113-114:149-58
PubMed ID: 15686114
|
|
3019
Akazawa, Akihiko, Nishikawa, Kazuhiro, Suzuki, Kazuyuki, Asano, Ryuji, Kumadaki, Itsumaru, Satoh, Haruna, Hagiwara, Kiyokazu, Shin, Sung Jae, Yano, Tomohiro
Induction of apoptosis in a human breast cancer cell overexpressing ErbB-2 receptor by alpha-tocopheryloxybutyric acid.
Jpn J Pharmacol
2002
89:417-21
PubMed ID: 12233821
|
|
6400
Hatano H, Kawashima H, Ogose A, Hotta T, Endo N.
A PCR-ELISA assay for the detection of disseminated osteosarcoma cells in a mouse metastatic model.
J Orthop Sci
2001
6(3):269-75
PubMed ID: 11484122
|
Back
Top
CELL BANK Website
